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Quantitative Metabolomics Reveals an Epigenetic
Blueprint for Iron Acquisition in Uropathogenic
Escherichia coli
Jeffrey P. Henderson1,2, Jan R. Crowley2, Jerome S. Pinkner1,3, Jennifer N. Walker3, Pablo Tsukayama3,
Walter E. Stamm4, Thomas M. Hooton5, Scott J. Hultgren1,3*
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Abstract
Bacterial pathogens are frequently distinguished by the presence of acquired genes associated with iron acquisition. The
presence of specific siderophore receptor genes, however, does not reliably predict activity of the complex protein
assemblies involved in synthesis and transport of these secondary metabolites. Here, we have developed a novel
quantitative metabolomic approach based on stable isotope dilution to compare the complement of siderophores
produced by Escherichia coli strains associated with intestinal colonization or urinary tract disease. Because uropathogenic E.
coli are believed to reside in the gut microbiome prior to infection, we compared siderophore production between urinary
and rectal isolates within individual patients with recurrent UTI. While all strains produced enterobactin, strong preferential
expression of the siderophores yersiniabactin and salmochelin was observed among urinary strains. Conventional PCR
genotyping of siderophore receptors was often insensitive to these differences. A linearized enterobactin siderophore was
also identified as a product of strains with an active salmochelin gene cluster. These findings argue that qualitative and
quantitative epi-genetic optimization occurs in the E. coli secondary metabolome among human uropathogens. Because
the virulence-associated biosynthetic pathways are distinct from those associated with rectal colonization, these results
suggest strategies for virulence-targeted therapies.
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search in the model uropathogen UTI89 revealed extensive
selection of 29 genes including those involved in synthesis of the
siderophore enterobactin [6]. These siderophore genes were also
subject to increased transcription during experimental urinary
tract infection [7]. Finally, PCR-based studies of candidate
virulence factor genes have identified high frequencies of siderophore receptor genes among urinary isolates although expression of the corresponding siderophores was not determined [8,9].
Siderophores are a chemically diverse family of small molecules
that are produced by a wide variety of pathogenic and nonpathogenic bacteria to scavenge ferric iron (Fe3+) [10]. During iron
scarcity, these bacteria synthesize and secrete siderophores, which
avidly bind ferric iron and become internalized. Siderophores
effectively compete with mammalian iron storage proteins and
may be of particular importance in acquiring this critical nutrient
during infection [11]. Additional horizontally-acquired genes
facilitating siderophore biosynthesis may confer new or enhanced
properties that may render a bacterium more virulent. To date,
genes for various combinations of four genetically distinct
siderophore systems have been described in clinical E. coli isolates

Introduction
Urinary tract infection (UTI) is a highly prevalent infectious
disease with a well-known female predilection and a high
incidence of recurrence [1]. E. coli is responsible for up to 85%
of community-acquired UTI, and previous studies suggest that the
same E. coli strain can cause recurrent UTI’s despite initial
antibiotic treatment [2,3,4]. UTI has classically been considered to
follow inoculation of the bladder through urethral ascension of
rectal flora [5]. Urethral ascension to the bladder is considered to
be more common in women due to their shorter urethral length
and facilitated by mechanical effects on the urethra during
intercourse, which is a major risk factor for UTI. The events
preceding clinical UTI where colonization progresses to symptomatic bacteriuria are poorly understood and difficult to study.
Whether selection of UTI-associated strains from gut E. coli
populations is stochastic or the result of intrinsic strain properties
has been the subject of multiple investigations. Genes involved
with iron acquisition routinely emerge as correlates of urinary
pathogenesis in these studies. In one such study, a genome-wide
PLoS Pathogens | www.plospathogens.org
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recurrent urinary tract infection have a preferred metabolomic
profile involving a complex metabolic network.

Author Summary
Urinary tract infections (UTIs) are among the most
common bacterial infections treated by physicians worldwide. Although symptoms of acute infection are often
resolved with a course of antibiotics, the same bacterial
strain often causes subsequent bouts of symptomatic
infection. Escherichia coli are the most common bacteria
causing UTI and the infecting strains are widely believed to
originate from the gastrointestinal tract where multiple E.
coli strains reside. Here, we use a novel mass spectrometric
technique in a population of patients with recurrent UTI to
identify how strains that cause UTI differ from other strains
that were present in the gastrointestinal tract at the same
time. We found that urinary E. coli strains preferentially
expressed two small molecules called yersiniabactin and
salmochelin. These molecules are called siderophores,
meaning they are able to scavenge iron to support
bacterial survival and growth. Synthesis and transport of
these small molecules requires a coordinated network of
proteins encoded by a collection of different genes. These
findings suggest that new antibiotics directed against
yersiniabactin or salmochelin-producing E. coli strains may
be an improved, and more targeted, strategy to prevent
recurrent UTIs.

Results
The secreted metabolome among clinical E. coli isolates
contains multiple siderophores
Siderophore production in 18 previously characterized UPEC
strains [14] isolated from the urine of women with UTI was
examined. To determine what siderophores are expressed by these
E. coli isolates, we compared culture supernatants from strains
grown for 18 hours in iron-poor and iron-rich minimal media
(Fig. 1, Table 2). Comparison of full scan LC-MS profiles from
each growth condition revealed a more abundant metabolite
signature in iron-poor cultures, consistent with induction of
siderophore expression during iron scarcity.
rUTI2 was chosen as a model strain to develop a quantitative
metabolomic approach because it produced all four known E. coli
siderophores. Thus, in iron-poor culture supernatants of strain
rUTI2 we identified chromatography peaks corresponding to the
[M+H]+ ions of aerobactin (14), salmochelin (15), and enterobactin (16), and the [M22H+Fe(III)]+ ion of ferric yersiniabactin
(17). These siderophore peaks elute from a reversed phase column
in the order reported previously (19). Confirmatory structural
information was available by comparing the m/z difference
between the [M+H]+ of salmochelin and its precursor, enterobactin. The salmochelin [M+H]+ is 342 m/z units greater (Fig. 2),
consistent with enterobactin di-C-glucosylation and trilactone
hydrolysis catalyzed by IroB and IroE, respectively (20, 21).
To further confirm the identity of presumptive siderophore ions,
rUTI2 was grown in defined minimal media in which 13C3-glycerol
or 15N-ammonium sulfate were substituted for the unlabeled
compounds. This heavy isotope labeling strategy resulted in mass
shifts for each ion peak based on the number of carbons or nitrogens
in their empiric formulae (Fig. 2). Labeling efficiency was high and
no unlabeled siderophores or M+1 or M+2 carbon isotope
distributions were observed for the most abundant 13C-labeled
enterobactin, salmochelin, and aerobactin ions. The prominent
M+1 and M+2 ions uniquely present in the 13C-labeled ferric
yersiniabactin spectrum are consistent with the presence of iron and
sulfur in this species. In this sample, the presence of a monoisotopic
13
C ion clearly differentiates the M+1 ion from 57Fe (base peak
contains 56Fe) and the M+2 ion from 34S (base peak contains 32S).
After mixing labeled and unlabeled supernatants, the labeled and
unlabeled siderophore ions all co-eluted, consistent with their
expected identical structures. This isotope labeling technique
provides both structural confirmation and a source of stable isotope
labeled internal standards for MS-based quantification.
MS/MS fragmentations were also studied for further structural
confirmation using strain rUTI2 (Table S1). The enterobactin
[M+H]+ at m/z 670 fragmented predominantly at the ester bonds
to yield dihydroxybenzoyl serine monomer (m/z 224) and dimer

with enterobactin being the only system conserved in all isolates
(Table 1). Among the non-conserved siderophores, the synthesis of
salmochelin is encoded in the iroA gene cluster, involving the IroBmediated glucosylation and IroE-mediated linearization of enterobactin. The Yersinia high pathogenicity island (HPI) encodes the
genes necessary for the synthesis and uptake of yersiniabactin.
Aerobactin biogenesis is encoded in the iucABCD cluster of genes.
In this study we have used a quantitative metabolomics
approach together with microbiologic, genomic, and clinical
strategies to uncover a preferential metabolic signature among
E. coli isolates from the urines of women with recurrent UTI
(urinary E. coli). Comparisons of coincident urinary and rectal
strains from patients with recurrent UTI revealed that urinary
strains exhibited significantly higher production of yersiniabactin
and salmochelin, even amongst genotype-positive strains, but not
enterobactin and aerobactin. Also, the siderophore receptor
genotype did not always correspond to production of the
associated siderophore, in contrast to previous assumptions
[8,12,13]. Thus, a quantitative metabolomic approach revealed
important differences in siderophore production not detectable by
genotyping alone. Our analysis of the metabolomic network
necessary for siderophore biosynthesis revealed that in addition to
its role in salmochelin biogenesis, IroE also converts a conserved
siderophore (enterobactin) into a more virulent one (linearized
enterobactin) better suited to the infectious microenvironment.
These studies demonstrate that E. coli strains associated with

Table 1. Siderophores described among E. coli strains used in this study.

enterobactin

salmochelin

yersiniabactin

aerobactin

type

catecholate

catecholate

thiazoline

hydroxamate

synthesis

entABCDEF [17,40]

iroB,E [19,28,41]

ybtSETU, irp1, irp2 [18,42]

iucABCD [43]

receptor

fepA [44]

iron [41]

fyuA [45]

iutA [43]

doi:10.1371/journal.ppat.1000305.t001
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565 fragmented to give the neutral losses of water (m/z 547) and
HCOOH (m/z 519) of a multiply hydroxylated and carboxylated
compound. MS/MS of ferric yersiniabactin [M22H+Fe(III)]+
gave a complex spectrum, as expected from a heterocyclic
compound, that included the prominent m/z 489 peak observed
in previous MALDI spectra [16]. Together, these ion fragmentation patterns were consistent with the known structures of the
corresponding siderophores. These MS/MS fragmentations were
used to quantify siderophores in a multiplexed LC-MS/MS assay.

Effect of mutations in siderophore biosynthetic genes on
metabolomic profile
The sequenced model uropathogen UTI89 was observed to
produce enterobactin, salmochelin, and yersiniabactin. To validate the stable isotope dilution LC-MS/MS metabolomic assay,
we analyzed UTI89 strains with deletion mutations in selected
siderophore biosynthetic genes (Fig. 3A). Ions corresponding to the
catecholate siderophores enterobactin and salmochelin were
absent in an entB [17] mutant while yersiniabactin production
was preserved. Conversely, the ybtS [18] mutant produced
enterobactin and salmochelin but not yersiniabactin. Because ybtS
encodes a salicylate synthase, yersiniabactin expression could be
restored in UTI89DybtS by growth in the presence of exogenous
0.3 mM sodium salicylate (data not shown). Selective loss of
salmochelin was observed with deletion of iroB, which forms Cglucose bonds with enterobactin [19]. These findings show that
metabolomic profiling is sensitive to alterations in siderophore
biosynthetic pathways.

Figure 1. LC-MS metabolite profiling reveals differential
product formation based on media iron content. Depicted are
total ion chromatograms of conditioned culture media following
18 hour culture of E. coli strain rUTI2 in M63 media containing 1 mM
(‘‘iron poor’’, top trace) or 100 mM ferric chloride (‘‘iron rich’’, top trace).
Mass spectrometric analysis confirms that the majority of differentially
expressed peaks in the iron poor supernatant derive from siderophores.
doi:10.1371/journal.ppat.1000305.g001

(m/z 446) as previously reported [15]. In contrast, MS/MS spectra
of salmochelin gave the distinct lower molecular weight species
expected from fragmentation within the glucose moieties, a finding
supported by unchanged neutral losses from 15N-labeled products.
Consistent with the hallmark C-glucosylation in salmochelin, we
observed no loss of glucose (neutral loss of m/z 162) as is typically
seen with O- or N-linked sugars. The aerobactin [M+H]+ at m/z

Table 2. Siderophore production in previously sequenced or genotyped strains.

strain

enterobactin

salmochelin

yersiniabactin

MS

MS

MS

aerobactin

fyuA

MS

iutA
2

MG1655

+

2

2

2

2

UTI89

+

+

+

+

2

2

CFT073

+

+

2

+

+

+

ASB1

+

+

+

+

2

2

ASB2

+

+

+

+

2

2

ASB3

+

+

+

+

+

+

ASB4

+

2

2

2

2

2

ASB5

+

+

+

+

2

2

acute1

+

+

+

+

+

+

acute2

+

2

2

2

2

2

acute3

+

+

+

+

2

2

acute4

+

+

+

+

2

2

rUTI1

+

2

2

2

2

2

rUTI2

+

+

+

+

+

+

rUTI3

+

+

+

+

2

2

rUTI4

+

2

+

+

2

+

rUTI5

+

+

+

+

+

+

pyelo1

+

2

2

+

2

2

pyelo2

+

2

2

2

2

2

pyelo3

+

2

2

+

2

+

pyelo4

+

+

+

+

+

+

The presence or absence of siderophore production as determined by mass spectrometry (MS) is indicated with the presence or absence of the corresponding
siderophore receptor genotype.
doi:10.1371/journal.ppat.1000305.t002
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Figure 2. Identity of E. coli siderophore peaks is confirmed by stable isotope substitution. E. coli strain rUTI2 was grown in M63 media
(top trace), with 15N-ammonium as the nitrogen source (middle trace), and with 13C-glycerol as the carbon source (bottom trace). The 13C-labeled
forms are used as internal standards for mass spectrometric quantification in this study.
doi:10.1371/journal.ppat.1000305.g002

Accountability of total siderophore activity using
genetics and metabolomics

on blue-to-yellow transformation surrounding streaked colonies
[20] (Fig. 3B). To determine whether enterobactin, salmochelin,
and yersiniabactin together correspond to the total siderophore
activity expressed by UTI89, we constructed a UTI89DentBDybtS
double mutant which was predicted to selectively abolish synthesis

Single deletion mutants in the siderophore biosynthetic
pathways described above (entB, ybtS, iroB) remained positive for
siderophore production by the chrome azurol S plate assay based
PLoS Pathogens | www.plospathogens.org
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Figure 3. Siderophore production by the model uropathogen UTI89 and selected mutants. A) MS/MS chromatograms showing
siderophore production in wild type UTI89 and strains with deletions in specific siderophore biosynthesis genes (DentB, DiroB, DybtS, DentB/DybtS).
Chromatograms are shown at the retention times for enterobactin (m/z 670), salmochelin (m/z 1012), and ferric yersiniabactin (m/z 535). For each
column, the vertical scale is a fixed fraction of the corresponding 13C internal standard peak height, allowing comparison between samples. B)
Chrome azurol S (CAS) plate upon which UTI89 strains have been streaked for overnight growth. A yellow halo is produced around siderophoresecreting bacteria. In UTI89, a double mutant (DentB/DybtS) is required to specifically abolish siderophore production.
doi:10.1371/journal.ppat.1000305.g003

those isolated from rectal swabs obtained up to one month prior to
isolation of a distinct urinary PFGE type. Thus, for this study 14
urinary and 16 rectal PFGE types were chosen from this set of 13
patients. Similarity analysis based on PFGE typing revealed
marked diversity (Fig. S1). Two patients yielded isolates with the
same PFGE type (Patients 34 and 50, Table 4), one from urine and
the other from the rectum. All 30 urinary and rectal strains from
these 13 patients exhibited similar growth patterns under ironlimited, minimal media conditions [mean difference 0.007; 2tailed p = 0.8273], indicating that observed metabolite differences
were not related to differences in growth density.

of all known siderophores in UTI89. Metabolomic profiling of
UTI89DentBDybtS confirmed the absence of all three siderophores
in this mutant and the chrome azurol S assay revealed unchanged
colony growth without siderophore production. Thus, for UTI89,
total siderophore activity is accountable using this metabolomic
analysis as confirmed using a combined biochemical, genetic, and
chemical approach. Unlike the K12 E. coli strains described
previously [21,22], a single mutation within the enterobactin gene
cluster is insufficient to abolish siderophore production from
UTI89.

Siderophore receptor genotype does not predict
expression of the corresponding siderophore

Differences in siderophore production between samepatient rectal and urinary strains

To compare siderophore expression phenotype to bacterial
genotype, we examined siderophore production by three fully
sequenced E. coli strains MG1655 [23], UTI89 [6], and CFT073
[24] and in our panel of 18 previously genotyped clinical E. coli
urinary isolates [14] described above (Table 2). The yersiniabactin
receptor (fyuA) and aerobactin receptor (iutA) genotypes were
known for all 21 strains. Of the 16 fyuA-positive strains, three
pyelonephritic strains, CFT073, pyelo1, and pyelo3 produced no
detectable yersiniabactin despite producing other siderophores. Of
the 8 iutA-positive strains, two, rUTI4 and pyelo3, produced no
detectable aerobactin while still producing other siderophores.
The inability of CFT073 to synthesize yersiniabactin is presumably due to mutations that have been identified within essential
yersiniabactin biosynthetic genes in this strain [25]. Thus, receptor
genotype does not consistently predict the cohort of siderophores
that are presented by an organism in response to low-iron
conditions.

To determine if quantitative and qualitative differences in the
siderophore metabolome distinguish urinary from rectal isolates in
this set of 13 patients, we used quantitative metabolomic profiling
and then compared these results to a genotypic analysis. In the
Table 3. Patient characteristics for paired strain study.

Variable

Case-Patients
(n = 13)

Age, %
18–30 y

85%

31–49 y

15%

Mean age6SE, y

24.261.5

Previous UTIs, %

Recovery of same-patient rectal-urinary E. coli strain pairs

0

To determine whether urinary E. coli strains exhibited
preferential siderophore expression when compared to distinct,
coincident rectal strains, we collected a new set of E. coli strains
from 18 recurrent UTI patients and we PFGE-typed the isolates
(this is a distinct set of isolates from those described in Table 2).
From this collection, we identified 13 patients in whom distinct,
coincident urinary and rectal PFGE types associated with a UTI
were recovered. Clinical characteristics of these 13 patients are
described in Table 3. Coincident rectal strains were defined as

1–4

46%

$5

54%

PLoS Pathogens | www.plospathogens.org

0%

#UTIs during study
1

1

2

7

3

5

doi:10.1371/journal.ppat.1000305.t003
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Table 4. Patient PFGE types, siderophore expression, and genotypes related to source and UTI event.

yersiniabactin

salmochelin

aerobactin

patient #

mst #

source

UTI #

MS

fyuA PCR

MS

iroN PCR

MS

iutA PCR

2

0288

U

1

2

2

+

+

2

2

3103

R

1

2

2

2

2

2

2

11

13

17

34

35

50

54

56

0380

U

1

2

2

2

2

2

2

1343

R

1

2

2

2

2

2

2
2

1995

R

1

2

2

2

2

2

0355

U

1,2,3

+

+

+

+

2

2

10727

R

1,2,3

+

+

+

+

2

2

0349

U

1

+

+

2

2

2

+

0396

R

1

2

2

2

2

2

2

2355

R

1

2

2

2

2

2

+

6746

U

1

+

+

+

+

2

2

8047

R

1

+

+

+

+

2

2

6747

U

1

+

+

+

+

2

2

10760

R

1

+

+

2

2

2

2

8049

U

1

+

+

+

+

2

2

6746

R

1

+

+

+

+

2

2

1109

U

1,2,3

+

+

2

2

2

2

10917

R

1,2

2

2

2

2

2

2

10920

R

3

2

2

2

2

2

2
2

10921

R

3

+

+

2

2

2

1126

U

1,2

+

+

+

+

2

+

1110

R

1,2

2

+

2

2

+

+
+

6748

U

1

+

+

+

+

+

10932

R

1

2

2

2

2

2

+

72

6745

U

1,2

2

2

2

2

2

2

10775

R

1,2

2

2

2

2

2

2

94

5790

U

1

+

+

2

+

2

2

9282

R

1

2

+

2

2

+

+

68

110

9282

U

2

2

+

2

2

+

+

13579

R

2

2

2

2

2

2

2

0378a

U

1

+

+

2

2

2

+

13590

R

1

+

+

2

2

+

+

The presence or absence of siderophore production as determined by mass spectrometry (MS) is indicated with the presence or absence of the corresponding
siderophore receptor genotype as determined by PCR.
mst, multilocus sequence type; R, rectal; U, urinary; UTI, urinary tract infection; MS, mass spectrometry.
doi:10.1371/journal.ppat.1000305.t004

strains in this study, prevalence was in the order enterobactin
(100%), yersiniabactin (71%), salmochelin (50%) and aerobactin
(14%). These data show that, while all strains made enterobactin, a
biosynthetically active Yersinia HPI and iroA cassette were common
among urinary isolates in this population and that production of
these siderophores may have a clinically evident impact on UTI
recurrence.

metabolomic analysis, we measured differences between coincident urinary and rectal strains within individual patients. For each
patient, the quantity of each siderophore produced by rectal
strains was subtracted from the quantity produced by the
coincident urinary strains to yield a difference (Fig. 4). In the
four patients from whom multiple coincident urinary and rectal
strains were recovered, the mean difference in siderophore
production is reported. This analysis revealed significantly
(p,0.05) higher salmochelin and yersiniabactin production among
urinary strains. It was also notable that we found no instances in
which the rectal-only strain produced yersiniabactin or salmochelin while the urine strain did not. Furthermore, urinary strains
always produced more salmochelin, even when non-urinary strains
also expressed salmochelin (n = 3) suggesting that salmochelin
biosynthesis was more active in urinary strains. Among all urinary
PLoS Pathogens | www.plospathogens.org

Comparison between siderophore expression and
siderophore receptor genotype
The siderophore expression analysis of the rectal and urinary
strains from the 13 patients described above was compared to
PCR genotyping using established PCR primers for siderophore
receptor genes (fyuA for yersiniabactin, iroN for salmochelin, iutA
for aerobactin) [8,26] (Table 4). Previous genotypic data
6
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Figure 4. Differences in siderophore production between single-patient urinary and rectal isolates. Each data point is the difference in
siderophore production between coincident urinary and rectal strains recovered from an individual with UTI. These differences were determined by
stable isotope dilution mass spectrometry and expressed in reference strain equivalents. The median and interquartile range is depicted for each
siderophore. *Medians differs significantly (p,0.05) from zero.
doi:10.1371/journal.ppat.1000305.g004

methods occurred in one patient with an iutA+ strain and in the
seven patients with iutA2 strains that produced no detectable
aerobactin. These data comparing PCR genotyping to product
analysis demonstrate that differences in biosynthetic activity are
not solely a reflection of the presence or absence of siderophore
gene loci.

suggesting that enterobactin genes are conserved among E. coli was
supported by product analysis, which revealed enterobactin
production by all patient isolates. For yersiniabactin and
salmochelin, the siderophore receptor genotyping analysis had
the limitation of being unable to discern strain differences when
both a rectal and urinary strain pair were genotype positive. This
was a frequent occurrence. In the ten patients from whom at least
one fyuA+ strain was recovered, product analysis revealed rectalurinary differences in yersiniabactin production in all ten, while
genotyping predicted differences in four. Similarly, in the eight
patients from whom at least one iroN+ strain was recovered,
product analysis revealed differential yersiniabactin production in
seven, while genotype predicted differential expression in four.
Among fyuA2 or iroN-positive strain pairs, mean and median
yersiniabactin or salmochelin production remained higher among
the urinary strains.
For aerobactin, differences between iutA PCR and product
analysis were even more striking. Aerobactin production was only
detected in four of nine iutA+ strains. As a result, differences in
siderophore production predicted by genotype were changed by
product analysis in four patients. Agreement between the two
PLoS Pathogens | www.plospathogens.org

Salmochelin and yersiniabactin expression are correlated
Yersiniabactin was the most prevelant non-enterobactin siderophore and strikingly, was co-expressed in 90% of the strains that
expressed salmochelin. This was the most frequent co-association
of any of the non-enterobactin siderophores (p = 0.006) and was
mirrored by a significant association between fyuA and iroN
positivity (p = 0.008). Salmochelin and yersiniabactin co-expression
was seen more often among patient urinary (6/13 (46%)) than
rectal (3/13 (23%)) strains, although this trend did not reach
statistical significance (p = 0.18). Thus, salmochelin expression
tended to occur in addition to yersiniabactin expression and coexpression was a common feature among urinary strains in this
population. These data raise the possibility that these two
siderophore types exhibit complementary activities.
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Figure 5. In addition to directing salmochelin biosynthesis, the iroA cluster also increases production of linear enterobactin, a
candidate virulence-associated siderophore. A) Cyclic enterobactin is converted into a linear form by ester bond hydrolysis. B) Clinical isolates
that produce salmochelin (+salmochelin) exhibit greater enterobactin linearization than salmochelin nonproducers (-salmochelin). C) Removal of the
entire iroA cluster (iroBCDEN) significantly reduced enterobactin linearization. A similar reduction in enterobactin linearization is seen in an iroE
mutant. Enterobactin linearization in MG1655, a K12 strain without the iroA cluster, was comparable to that seen in these mutants. These findings
support the esterase IroE as an enterobactin linearizing enzyme in vivo.
doi:10.1371/journal.ppat.1000305.g005

the absence of the iroA genes has been observed previously and
may derive from premature release during biosynthesis [29],
cleavage of ferric enterobactin by the enterobactin esterase Fes, or
spontaneous ester bond hydrolysis. Together, these data show that,
in addition to synthesizing salmochelin, iroA also directs enterobactin linearization through the action of the esterase IroE to
produce linear enterobactin, a siderophore that may be better
suited to iron-scavenging during infection.

Enterobactin linearization is an additional virulence
activity of strains with an active iroA cassette and is
consistent with IroE esterase activity
Clinical isolates were noted to produce varying amounts of
linearized enterobactin, which is distinguished by a distinct
retention time and an ion at m/z 688, consistent with hydrolysis
(+18 amu) of a single ester bond (Fig. 5A). While somewhat slower
at scavenging iron than enterobactin, it has been proposed that
linear enterobactin is better suited to avoid sequestration by
hydrophobic surfaces [27]. Enterobactin linearization was quantified by the precursor/product relation:

Discussion
We have used a combined chemical, genetic, and patientoriented approach to examine clinical correlates of siderophore
production among human E. coli isolates associated with recurrent
urinary tract infection. Development of a quantitative metabolomic approach allowed assessment of the complex multiprotein
biosynthetic pathways for siderophores rather than inferring these
activities from genotype or transcription analysis alone. PCR
genotyping of a single siderophore system gene was not an efficient
predictor of siderophore production during iron-restricted growth.
Thus, the quantitative metabolomic approach was used to
determine whether successful uropathogens exhibit systematic
differences from coexisting rectal and urinary strains in individual
patients. Rather than comparing strains across a population, we
examined strain differences within individual patients in order to
compare each urinary strain to a more valid reference population.
This study compares siderophore production between coexisting bacterial strains associated with urinary disease and gut
colonization. Since uropathogens are thought to arise from the gut
flora, comparison of these populations should represent the most

linearization~½linear enterobactin=½enterobactin
Salmochelin expressors exhibited over threefold higher enterobactin linearization than non-expressor strains (Fig. 5B). To
explore genetic correlates of this relationship, we examined
enterobactin linearization among mutants in the iroA gene cluster
in UTI89 (Fig. 5C). Mutants containing a deletion of the iroA gene
cluster were unable to express salmochelin and exhibited a
decrease in enterobactin linearization compared to the wild type
control. Similar low levels of linear enterobactin were observed in
clinical isolates that did not express salmochelin. To determine
whether this linearizing activity was attributable to the esterase
IroE [28], we examined enterobactin linearization in an iroE
mutant. Linearization by the iroE mutant was decreased to the
same levels as in the K12 strain MG1655, which lacks all of the
iroA genes. The remaining baseline level of linear enterobactin in
PLoS Pathogens | www.plospathogens.org
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that qualitative shifts in siderophore type may be more conducive
to uropathogenesis than a quantitative shift in enterobactin
production. Although iutA positivity among pathogenic strains is
often used to conclude that aerobactin is an important virulence
factor, we did not observe preferential expression of this
siderophore when urinary and rectal isolates were compared.
The sample size may not have allowed us to discern preferential
aerobactin production in this population. Alternatively, iutApositive clinical isolates might exhibit urinary virulence properties
that are unrelated to aerobactin production.
These results suggest that yersiniabactin and salmochelin
expression may facilitate infection of the human urinary tract.
This effect is not absolute, as there are urinary strains in this study
that express neither siderophore. Although rectal isolates in this
and other studies [32] have been observed to produce yersiniabactin and/or salmochelin, the impact of these siderophores upon
fitness for gut colonization is unclear. The relatively high
prevalence of yersiniabactin and salmochelin expression among
urinary pathogens (Table 5), makes these nonessential metabolic
pathways intriguing prospects for virulence-targeted therapies.
Interestingly, the yersiniabactin and salmochelin biosynthetic
pathways converge at chorismic acid, where each pathway uses
related enzymes to synthesize the aromatic precursors 2-hydroxybenzoic (salicylic) acid and 2,3-dihydroxybenzoic acid (Fig. 6).
Targeting either or both of these initial points in siderophore
biosynthesis may represent a promising target for anti-virulence
drug discovery or design.

Table 5. Prevalence of detectable siderophore expression
among different PFGE types in this study according to source.

siderophore
expressed

urinary source
(n = 14)

rectal source
(n = 16)

enterobactin

100% (14)

100% (14)

yersiniabactin

71% (10)

31% (5)

salmochelin

50% (7)

13% (2)

aerobactin

14% (2)

25% (4)

The number of strains in each category is indicated in parentheses.
doi:10.1371/journal.ppat.1000305.t005

valid study design. The dichotomy between commensalism and
pathogenicity is a common theme among bacteria and is
particularly compelling in the case of E. coli urinary tract
infections. Siderophore expression has been linked to virulence
and here we show that yersiniabactin and salmochelin were the
most common non-enterobactin siderophores associated with UTI
recurrence in this typical young female population. Notably,
yersiniabactin synthesis was observed in almost all strains that
expressed salmochelin. In this study population of young women
with recurrent UTI, urinary strains produced greater amounts of
two siderophores, yersiniabactin and salmochelin and co-expression of both of these siderophores was common.
In this study, quantitative product analysis provided information
beyond conventional siderophore receptor genotyping in two
circumstances: 1) when a genotype-positive strain was unable to
produce detectable levels of the corresponding siderophore and 2)
when siderophore production differed significantly between
genotype-positive strain pairs. Ten of the thirteen patients in this
study yielded at least one strain pair in which either or both of
these circumstances was operative. Deficient or enhanced siderophore biosynthesis may arise in multiple environmental
contexts. Pathogenic bacteria may benefit from increased
production of siderophores that are better adapted to the infection
microenvironment, as may be the case with salmochelin and
yersiniabactin. Alternatively, bacterial strains in polymicrobial
communities may benefit from inactivated siderophore production
if they retain the ability to ‘‘steal’’ ferric siderophores produced by
a neighbor, thereby avoiding the metabolic cost of siderophore
biosynthesis [30,31]. Thus, extrapolation of siderophore receptor
genotype to biosynthetic phenotype is inefficient, often inaccurate
and suggests that optimization of siderophore biosynthesis may
occur in pathogenic strains.
Enterobactin or aerobactin production was not preferentially
associated with urinary strains in this population. The lack of
increased enterobactin production among urinary strains suggests

Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of the University of Washington. All
patients provided written informed consent for the collection of
samples and subsequent analysis.

Bacterial strains and cultivation
To examine siderophore production in liquid culture, previously
published conditions were used [33]. 3 hour cultures of E. coli
grown in LB broth were diluted 1:100 into M63 medium
containing 0.2% glycerol and 10 mg/mL niacin and incubated
for 18 h at 37 C in a rotary shaker.

Deletion strain construction
Deletion mutations were made using the red recombinase
method, as previously described, using pKD4 or pKD13 as a
template and the primers as listed in Table S2. [34,35] PCR was
performed with flanking primers to confirm the appropriate

Figure 6. Biosynthesis of siderophores associated with recurrent UTI depends on chorismic acid utilization.
doi:10.1371/journal.ppat.1000305.g006
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deletions. Antibiotic insertions were removed by transforming the
mutant strains with pCP20 [36] expressing the FLP recombinase.
The resultant strains subsequently had no additional antibiotic
resistance compared with the parental wt strain.

standard peak. These peak area ratios were then converted to
molar ratios by comparison to standard curves generated by
mixing known ratios of unlabeled and labeled rUTI2 supernatants.
Siderophore quantities were expressed as rUTI2 equivalents by
normalizing each molar ratio to that observed for strain rUTI2
under identical culture conditions.

Liquid chromatography-mass spectrometry (LC-MS)
The mass spectrometer used for the studies was a ThermoFinnigan LCQ Deca (San Jose, CA) coupled to a Waters CapLC
(Waters MA) equipped with a Vydac C18 MS column
(0.36150 mm). The flow rate was 6 ul/min with a gradient as
follows: Solvent A (0.1% formic acid) was held constant at 95%
and solvent B (80% acetonitrile in 0.1% formic acid) was held
constant at 5% for 5 minutes, increased to 44% B in the next
60 minutes, and then to 95% B in the next 20 minutes. All data
was collected in a positive mode. The spray voltage on the mass
spectrometer was held constant at 4.5 K and the capillary
temperature was 200uC. For CID experiments helium was used
as the collision gas with the collision energy set to 32% of the
maximum (,5 eV). The isolation width was 3 amu. Quantitation
was carried out in the SRM mode using 13C labeled standards as
described above. Data was collected in the positive centroid mode.
Ions were monitored with a window of +/20.5 amu.

PCR analysis
Isolates were grown to log phase on 5 ml LB medium. Primer
combinations FyuA f’–FyuA r (880 bp product)/AerJ f–AerJ r
(300 bp)/IRONEC-F–IRONEC-R (665 bp) were used for amplification of fyuA, iutA, and iroN genes, respectively [12,37]
Amplification reactions were carried out individually in a BioRad MyCycler instrument using 5 ml of heat-inactivated culture
and 35 cycles of 956300/576300/726600.

Patients and strains
Patients presenting with UTI were enrolled and monitored
prospectively as described previously [14]. Rectal specimens were
collected during clinic visits using a sterile, rayon-tipped swab and
transported to the laboratory in Amies Medium (BBLTM
CultureSwabTM Plus, Becton, Dickinson). To avoid inclusion of
rectal strains that may have been introduced after the UTI event
or that may have been only transiently present [38,39] prior to the
UTI event, rectal strains were excluded if they were recovered
after or .30 days before the urinary isolate.

Siderophore extraction
0.1 M ferric chloride was added to cell supernatants to a final
concentration of 3.75 mM. After a 15 minute room temperature
incubation the precipitate was removed by centrifugation. The
supernatant was applied to a column packed with 200 uL of
DEAE slurry [33]. The loaded column was washed with 0.5 mL of
water and siderophores were eluted with 3 mL of 7.5 M
ammonium formate adjusted to pH 3.6 with 7.5 M formic acid.
The DEAE eluate was further purified and desalted by application
to a Chrom P solid phase extraction column (250 mg, Supelco).
The loaded column was washed with 2 mL of 0.1% formic acid in
10% acetonitrile. Siderophores were eluted following application
of 2 mL of 0.1% formic acid in 80% acetonitrile. The eluate was
then concentrated to 100–200 uL final volume in a centrifugal
evaporator for MS analysis.

Preparation of

13

Statistical analysis
Statistics and graphs were generated using GraphPad Prism 4.
For groupwise comparisons of siderophore production, the MannWhitney U Test was performed. Analyses of paired strain
differences in siderophore production were performed using the
Wilcoxon signed rank test for significance. For analysis of
stationary phase density, the data passed the F test for equal
variances and the t test was used to compare urinary versus rectal
strain growth as well as growth differences between paired strains.
Categorical data was analyzed using Fisher’s exact test.

Supporting Information

C-labeled internal standards

Internal standards were produced by rUTI2, a clinical urine
isolate found to express all four known E. coli siderophore types, or
UTI89. Strains were each grown for 3 hours in LB broth, which
was subsequently inoculated 1:100 into M63 medium containing
0.2% 13C3-glycerol (99+ atom %, Isotec), and 10 mg/mL niacin
and incubated for 18 h at 37 C in a rotary shaker. Cells were
removed by centrifugation and a frozen stock of supernatant was
kept for use as internal standard. Isotopic labeling was confirmed
by LC-MS.

Table S1 CID fragmentations used to identify and quantify
siderophores by LC-MS/MS.
Found at: doi:10.1371/journal.ppat.1000305.s002 (0.03 MB
DOC)

Quantification of siderophores using stable isotope
dilution mass spectrometry

Table S2 Primers used in construction of UTI89 mutants.
Found at: doi:10.1371/journal.ppat.1000305.s003 (0.02 MB
DOC)

Figure S1 Dendrogram, PFGE patterns, siderophore status and
hemolytic properties of patient strains collected for comparison of
urinary strains with coexisting rectal strains.
Found at: doi:10.1371/journal.ppat.1000305.s001 (4.89 MB TIF)

Strains to be compared, along with the reference strain rUTI2,
were prepared together on the same day using the same media,
reagents, and internal standard. Siderophore quantities are
expressed as reference strain equivalents determined through the
stable isotope dilution method. 13C-labeled internal standard was
added 1:1 to each clarified culture supernatant and mixed prior to
siderophore extraction. Siderophore extracts subject to comparison were then prepared and analyzed by LC-MS/MS using the
parent and daughter ions described above and listed in Table S1.
Each siderophore type was first quantified by determining the
ratio of the analyte peak to the co-eluting 13C-labeled internal

PLoS Pathogens | www.plospathogens.org

Acknowledgments
We thank Tom Hannan, Jennifer Jones and Marsha Cox for technical
assistance.

Author Contributions
Conceived and designed the experiments: JPH SJH. Performed the
experiments: JPH JRC PT. Analyzed the data: JPH JRC PT. Contributed
reagents/materials/analysis tools: JPH JSP JNW WES TMH SJH. Wrote
the paper: JPH SJH.

10

February 2009 | Volume 5 | Issue 2 | e1000305

E. coli Metabolome in UTI

References
1. Foxman B (2002) Epidemiology of urinary tract infections: incidence, morbidity,
and economic costs. Am J Med 113 Suppl 1A: 5S–13S.
2. Ronald A (2003) The etiology of urinary tract infection: traditional and
emerging pathogens. Dis Mon 49: 71–82.
3. Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE (1995)
Chromosomal restriction fragment length polymorphism analysis of Escherichia
coli strains causing recurrent urinary tract infections in young women. J Infect
Dis 172: 440–445.
4. Foxman B, Zhang L, Tallman P, Palin K, Rode C, et al. (1995) Virulence
characteristics of Escherichia coli causing first urinary tract infection predict risk
of second infection. J Infect Dis 172: 1536–1541.
5. Kunin CM, Polyak F, Postel E (1980) Periurethral bacterial flora in women.
Prolonged intermittent colonization with Escherichia coli. Jama 243: 134–139.
6. Chen SL, Hung CS, Xu J, Reigstad CS, Magrini V, et al. (2006) Identification of
genes subject to positive selection in uropathogenic strains of Escherichia coli: a
comparative genomics approach. Proc Natl Acad Sci U S A 103: 5977–5982.
7. Reigstad CS, Hultgren SJ, Gordon JI (2007) Functional genomic studies of
uropathogenic Escherichia coli and host urothelial cells when intracellular
bacterial communities are assembled. J Biol Chem 282: 21259–21267.
8. Johnson JR, Kaster N, Kuskowski MA, Ling GV (2003) Identification of
urovirulence traits in Escherichia coli by comparison of urinary and rectal E. coli
isolates from dogs with urinary tract infection. J Clin Microbiol 41: 337–345.
9. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O’Bryan TT, et al. (2005)
Phylogenetic and pathotypic comparison of concurrent urine and rectal
Escherichia coli isolates from men with febrile urinary tract infection. J Clin
Microbiol 43: 3895–3900.
10. Raymond KN, Dertz EA, Kim SS (2003) Enterobactin: an archetype for
microbial iron transport. Proc Natl Acad Sci U S A 100: 3584–3588.
11. Jurado RL (1997) Iron, infections, and anemia of inflammation. Clin Infect Dis
25: 888–895.
12. Johnson JR, Stell AL (2000) Extended virulence genotypes of Escherichia coli
strains from patients with urosepsis in relation to phylogeny and host
compromise. J Infect Dis 181: 261–272.
13. Johnson JR, O’Bryan TT, Kuskowski M, Maslow JN (2001) Ongoing horizontal
and vertical transmission of virulence genes and papA alleles among Escherichia
coli blood isolates from patients with diverse-source bacteremia. Infect Immun
69: 5363–5374.
14. Garofalo CK, Hooton TM, Martin SM, Stamm WE, Palermo JJ, et al. (2007)
Escherichia coli from urine of female patients with urinary tract infections is
competent for intracellular bacterial community formation. Infect Immun 75:
52–60.
15. Berner I, Greiner M, Metzger J, Jung G, Winkelmann G (1991) Identification of
enterobactin and linear dihydroxybenzoylserine compounds by HPLC and ion
spray mass spectrometry (LC/MS and MS/MS). Biol Met 4: 113–118.
16. Chambers CE, McIntyre DD, Mouck M, Sokol PA (1996) Physical and
structural characterization of yersiniophore, a siderophore produced by clinical
isolates of Yersinia enterocolitica. Biometals 9: 157–167.
17. Rusnak F, Liu J, Quinn N, Berchtold GA, Walsh CT (1990) Subcloning of the
enterobactin biosynthetic gene entB: expression, purification, characterization,
and substrate specificity of isochorismatase. Biochemistry 29: 1425–1435.
18. Kerbarh O, Ciulli A, Howard NI, Abell C (2005) Salicylate biosynthesis:
overexpression, purification, and characterization of Irp9, a bifunctional
salicylate synthase from Yersinia enterocolitica. J Bacteriol 187: 5061–5066.
19. Fischbach MA, Lin H, Liu DR, Walsh CT (2005) In vitro characterization of
IroB, a pathogen-associated C-glycosyltransferase. Proc Natl Acad Sci U S A
102: 571–576.
20. Schwyn B, Neilands JB (1987) Universal chemical assay for the detection and
determination of siderophores. Anal Biochem 160: 47–56.
21. Cox GB, Gibson F, Luke RK, Newton NA, O’Brien IG, et al. (1970) Mutations
affecting iron transport in Escherichia coli. J Bacteriol 104: 219–226.
22. Pettis GS, McIntosh MA (1987) Molecular characterization of the Escherichia
coli enterobactin cistron entF and coupled expression of entF and the fes gene.
J Bacteriol 169: 4154–4162.
23. Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, et al. (1997) The
complete genome sequence of Escherichia coli K-12. Science 277: 1453–1474.
24. Welch RA, Burland V, Plunkett G 3rd, Redford P, Roesch P, et al. (2002)
Extensive mosaic structure revealed by the complete genome sequence of
uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 99: 17020–17024.

PLoS Pathogens | www.plospathogens.org

25. Bultreys A, Gheysen I, de Hoffmann E (2006) Yersiniabactin production by
Pseudomonas syringae and Escherichia coli, and description of a second
yersiniabactin locus evolutionary group. Appl Environ Microbiol 72:
3814–3825.
26. Johnson JR, Kuskowski MA, Gajewski A, Soto S, Horcajada JP, et al. (2005)
Extended virulence genotypes and phylogenetic background of Escherichia coli
isolates from patients with cystitis, pyelonephritis, or prostatitis. J Infect Dis 191:
46–50.
27. Luo M, Lin H, Fischbach MA, Liu D, Walsh C, et al. (2006) Enzymatic
Tailoring of Enterbactin Alters Membrane Partitioning and Iron Acquisition.
ACS Chemical Biology 1: 29–32.
28. Lin H, Fischbach MA, Liu DR, Walsh CT (2005) In vitro characterization of
salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes. J Am
Chem Soc 127: 11075–11084.
29. Guo ZF, Jiang M, Zheng S, Guo Z (2008) Suppression of linear side products by
macromolecular crowding in nonribosomal enterobactin biosynthesis. Org Lett
10: 649–652.
30. Griffin AS, West SA, Buckling A (2004) Cooperation and competition in
pathogenic bacteria. Nature 430: 1024–1027.
31. Kadner RJ, Heller K, Coulton JW, Braun V (1980) Genetic control of
hydroxamate-mediated iron uptake in Escherichia coli. J Bacteriol 143:
256–264.
32. Valdebenito M, Crumbliss AL, Winkelmann G, Hantke K (2006) Environmental factors influence the production of enterobactin, salmochelin, aerobactin, and
yersiniabactin in Escherichia coli strain Nissle 1917. Int J Med Microbiol 296:
513–520.
33. Valdebenito M, Bister B, Reissbrodt R, Hantke K, Winkelmann G (2005) The
detection of salmochelin and yersiniabactin in uropathogenic Escherichia coli
strains by a novel hydrolysis-fluorescence-detection (HFD) method. Int J Med
Microbiol 295: 99–107.
34. Datsenko KA, Wanner BL (2000) One-step inactivation of chromosomal genes
in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:
6640–6645.
35. Murphy KC, Campellone KG (2003) Lambda Red-mediated recombinogenic
engineering of enterohemorrhagic and enteropathogenic E. coli. BMC Mol Biol
4: 11.
36. Cherepanov PP, Wackernagel W (1995) Gene disruption in Escherichia coli:
TcR and KmR cassettes with the option of Flp-catalyzed excision of the
antibiotic-resistance determinant. Gene 158: 9–14.
37. Johnson JR, Russo TA, Tarr PI, Carlino U, Bilge SS, et al. (2000) Molecular
epidemiological and phylogenetic associations of two novel putative virulence
genes, iha and iroN(E. coli), among Escherichia coli isolates from patients with
urosepsis. Infect Immun 68: 3040–3047.
38. Sears HJ, Brownlee I, Uchiyama JK (1950) Persistence of individual strains of
Escherichia coli in the intestinal tract of man. J Bacteriol 59: 293–301.
39. Sears HJ, Brownlee I (1952) Further observations on the persistence of individual
strains of Escherichia coli in the intestinal tract of man. J Bacteriol 63: 47–57.
40. Shaw-Reid CA, Kelleher NL, Losey HC, Gehring AM, Berg C, et al. (1999)
Assembly line enzymology by multimodular nonribosomal peptide synthetases:
the thioesterase domain of E. coli EntF catalyzes both elongation and
cyclolactonization. Chem Biol 6: 385–400.
41. Hantke K, Nicholson G, Rabsch W, Winkelmann G (2003) Salmochelins,
siderophores of Salmonella enterica and uropathogenic Escherichia coli strains,
are recognized by the outer membrane receptor IroN. Proc Natl Acad Sci U S A
100: 3677–3682.
42. Miller DA, Luo L, Hillson N, Keating TA, Walsh CT (2002) Yersiniabactin
synthetase: a four-protein assembly line producing the nonribosomal peptide/
polyketide hybrid siderophore of Yersinia pestis. Chem Biol 9: 333–344.
43. de Lorenzo V, Bindereif A, Paw BH, Neilands JB (1986) Aerobactin biosynthesis
and transport genes of plasmid ColV-K30 in Escherichia coli K-12. J Bacteriol
165: 570–578.
44. Wookey P, Rosenberg H (1978) Involvement of inner and outer membrane
components in the transport of iron and in colicin B action in Escherichia coli.
J Bacteriol 133: 661–666.
45. Rakin A, Saken E, Harmsen D, Heesemann J (1994) The pesticin receptor of
Yersinia enterocolitica: a novel virulence factor with dual function. Mol
Microbiol 13: 253–263.

11

February 2009 | Volume 5 | Issue 2 | e1000305

